Real World Evidence (RWE) 

On November 12, more than 50 managed care professionals and various health care stakeholders gathered in Old Town Alexandria, Virginia to examine these barriers to adoption for RWE in managed care.

The Academy of Managed Care Pharmacy (AMCP) supports scientifically sound research that compares the effectiveness and value of prescription drugs, as well as research aimed at tailoring treatment options to individual patients’ needs.

Host Fred Goldstein invites Elizabeth Powers, Vice President, General Manager of Regulatory Science and Study Innovation at IQVIA to discuss real-world evidence (RWE).

In this webinar, you'll explore the impact of RSV on U.S. infants, examine key clinical studies on nirsevimab, and review global real-world data on its effectiveness. You'll also learn how to implement immunization strategies to reduce RSV lower respiratory tract infections (LRTI), with practical takeaways for improving coverage and reimbursement decisions.

The Academy of Managed Care Pharmacy (AMCP) today launched the AMCP Research Institute (ARI), a research-based resource that will conduct and facilitate projects important to the mission of managed care pharmacy. Incorporating AMCP’s existing Biologics & Biosimilars Collective Intelligence Consortium (BBCIC), the ARI will expand the scope of research opportunities for AMCP, thereby helping to advance the larger goal of improving public health in the United States.

AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship and selects Daria Sinclair of Howard University to be the first Health Disparities Research Intern.

Host Fred Goldstein invites Charles Makin, Global HEOR, RWE and Market Access Advisor to discuss their poster at AMCP Nexus 2023 on RWE adoption by US Payers.

From best practices in managing obesity to the latest and greatest in gene and cell therapies, guest blogger Steve Kheloussi highlights three reasons he will be attending AMCP eLearning Day.

Andrey Ostrovsky, MD, FAAP, and Lisa Palko, PharmD, discuss the ADHD landscape, challenges, and progress, including Akili's digital therapeutics value proposition as the first FDA-authorized prescription video game treatment.